Except for stage I or part of stage II estrogen receptor positive (ER+)/human epidermal growth factor receptor 2 negative (Her2-) breast cancer patients, nearly all other breast cancer patients should undergo chemotherapy to gain a better prognosis 2-4. The gene discussed is ERBB2; the disease is breast carcinoma.